Cite
APA Citation
Gettinger, S., Hellmann, M., Shepherd, F., Antonia, S., Brahmer, J., Chow, L., Goldman, J., Juergens, R., Borghaei, H., Ready, N., Gerber, D., Nathan, F., Shen, Y., Harbison, C., & Rizvi, N. (n.d.). 3096 First-line monotherapy with nivolumab (NIVO) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy, and biomarker analyses. European journal of cancer, 51, S632–. http://access.bl.uk/ark:/81055/vdc_100030628321.0x000041